1. Centers for Disease Control and Prevention; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (United States). Incidence, prevalence, and cost of sexually transmitted infections in the United States; CDC fact sheet. http://www.cdc.gov/std/stats/sti-estimates-fact-sheet-feb-2013.pdf.
2. Centers for Disease Control and Prevention. Reported STDs in the United States: 2013 national data for chlamydia, gonorrhea and syphilis; CDC fact sheet. http://www.cdc.gov/nchhstp/newsroom/docs/STD-Trends-508.pdf.
3. Centers for Disease Control and Prevention. 2013 sexually transmitted diseases surveillance Table 45. Selected STDs and complications—initial visits to physicians' offices, National Disease and Therapeutic Index, United States, 1966-2013. http://www.cdc.gov/std/stats13/tables/45.htm.
4. Workowski K, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted disease treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1-137.
5. Wan YL, Edmondson RJ, Crosbie EJ. Intermenstrual and postcoital bleeding. Obstet Gynaecol Reprod Med. 2015;25(4):106-112.
6. U.S. Preventive Services Task Force. Final Recommendation Statement: Chlamydia and Gonorrhea: Screening. http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/chlamydia-and-gonorrhea-screening?ds=1&s=chlamydia%20and%20gonorrhea%20screening. Accessed July 25, 2015
7. Manhart LE, Broad JM, Golden MR. Mycoplasma genitalium: should we treat and how? Clin Infect Dis. 2011;53(Suppl 3):S129-S142.
8. Centers for Disease Control and Prevention. Update to CDC's sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep. 2012;61(31):590-594.